CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Our company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Our products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding.
As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates.
We strive to meet the challenges we face by centering our company around collaborative interaction, efficient problem-solving, and consistent customer satisfaction. With rapid advances in technology apparent and imminent, we recognize that it is crucial to offer solutions that are not only original and inventive, but also flexible and scalable and backed by industry-leading support and services. As a pioneer in its field and industry, CapitalBio Technology is able to provide these services for the research community in genomics, proteomics and metabolomics.
